首页 › 基金 › Andera Partners › MLYS

Andera Partners 对 MLYS 的持仓历史

Mineralys Therapeutics, Inc. · 医疗保健

Andera Partners 在 Q3 2026 的 13F 申报中披露持有 MLYS(Mineralys Therapeutics, Inc.)1,591,917 股,市值约 US$40.0M,约占其申报组合的 22.77%,在其申报持仓中市值排名第 2 位。 Andera Partners 最近 4 个申报季度中有 4 个季度披露了 MLYS 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)1.59M 股
申报持仓市值$40.00M
组合权重22.77%
首次申报Q4 2025
最近变动持有
更新于2026-10-17

最后更新: 2026-10-17 · 来源: SEC EDGAR Form 13F-HR

Andera Partners 对 MLYS 的持仓演变

Andera Partners 于 Q4 2025 首次披露 MLYS 持仓:1,591,917 股(约 US$57.8M)。 在 4 次申报中,Andera Partners 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 1,591,917 股、市值约 US$40.0M。

逐季持仓明细

季度股数金额变化
Q4 2025 1.59M $57.77M 新进
Q1 2026 1.59M $43.13M 持有
Q2 2026 1.59M $42.95M 持有
Q3 2026 1.59M $40.00M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 MLYS 与 13F 数据

MLYS(Mineralys Therapeutics, Inc.)属于医疗保健行业。我们追踪的基金中还有 53 只申报持有 MLYS,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$207.6M), Catalys Pacific, LLC (US$196.0M), Samsara BioCapital, LLC (US$158.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 MLYS 的基金

查看 MLYS 的全部基金持有人 →

常见问题

How long has Andera Partners held MLYS?

Andera Partners has disclosed MLYS holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Andera Partners's current position in MLYS?

As of Q3 2026, Andera Partners holds 1.59M shares of MLYS (Mineralys Therapeutics, Inc.), valued at $40.00M, representing 22.77% of its reported portfolio and ranking #2.

Has Andera Partners been buying or selling MLYS?

In the latest 13F filing (Q3 2026), Andera Partners held unchanged its position in MLYS.

Which other funds hold MLYS?

Other major institutional holders of MLYS include RA CAPITAL MANAGEMENT, L.P., Catalys Pacific, LLC, Samsara BioCapital, LLC, among 53 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.